Financial needs by sector
Malaria prevention represents the highest cost, at around US$3.7-3.9 billion annually from 2010 up to 2020. Most of these costs are almost equally distributed between indoor residual spraying (IRS, 55%) and long lasting insecticidal nets (LLINs, at almost 45%), with a more limited need for intermittent preventive treatments (for children, infants, pregnant women – IPT, less than 1%). Cost efficiencies in this area can have a major impact in reducing the funding requirements.
Case management (rapid diagnostic testing, artemisinin-based combination therapy, drugs to address other malaria strains and management of severe malaria) represents another important component of costs in the initial scale up. Successful prevention and a reduction of over-treatment of fevers with antimalarials can decrease significantly the cost of case management subsequently.
Programme support, in the form of infrastructure, monitoring and evaluation, operational research at country level, training, salaries and other costs for the deployment of community health workers, is estimated to remain relatively stable between 2012 and 2015. Health system synergies help compress these costs.
Summary costs at key points in time
|Cost (US$ millions)||2010||2015||2020||2025|
|Case management cost||1,359||550||226||87|
|Total cost for global control and elimination||6,180||5,037||4,877||3,378|